Zobrazeno 1 - 10
of 831
pro vyhledávání: '"J. Hazes"'
Publikováno v:
Annals of the Rheumatic Diseases. 81:633.1-633
BackgroundActive systemic lupus erythematosus (SLE) and nephritis due to SLE contribute to poor pregnancy outcomes. (1, 2) A meta-analysis has shown a relative risk of 1.51 for miscarriage in SLE patients compared to women without SLE. (3) The risk i
Autor:
F. R. Kasiem, L. Tucker, M. Vis, J. Luime, I. Tchetverikov, K. Wervers, J. Hazes, L. Coates, M. R. Kok
Publikováno v:
Annals of the Rheumatic Diseases. 81:847.1-847
BackgroundPsoriatic arthritis (PsA) is a heterogeneous, immune-mediated inflammatory arthritis. Methotrexate (MTX) is the first-line treatment in PsA patients, despite diverse clinical phenotypes and highly varied responses(1). As yet, it is not poss
Publikováno v:
Annals of the Rheumatic Diseases. 81:868.2-869
BackgroundPsoriatic arthritis (PsA) is a complex, chronic auto-immune disease that affects health-related Quality of Life (HRQoL). Earlier research showed that general HRQoL in PsA patients is mainly affected by musculoskeletal pain.1 However, psoria
Publikováno v:
Annals of the Rheumatic Diseases. 81:83.2-83
BackgroundTumor necrosis factor-α inhibitors (TNFis) such as certolizumab pegol (CZP), are a subgroup of biologics, which have shown no increase in risk of congenital malformations (CMs) after use during pregnancy. (1) However, for the subgroup of n
Publikováno v:
Annals of the Rheumatic Diseases. 81:627.2-628
BackgroundThe use of long-term corticosteroids during pregnancy has been growing over the past decades1. Corticosteroids can be given when an auto-inflammatory disease like rheumatoid arthritis (RA) is too active. Several studies have shown that long
Publikováno v:
Annals of the Rheumatic Diseases. 79:635-636
Background:In rheumatoid arthritis (RA) disease outcomes have improved enormously in the last decades. Due to early initiation of therapy, a treat-to-target approach and a growing arsenal of disease-modifying antirheumatic drugs (DMARDs) and biologic
Publikováno v:
Annals of the Rheumatic Diseases. 79:175.2-175
Background:Current guidelines recommend to consider tapering treatment in rheumatoid arthritis (RA) patients who are in sustained remission, but the optimal approach to de-escalate conventional synthetic and biological DMARDs (respectively csDMARDs a
Autor:
D. Ten Cate, J. Jacobs, W. Swen, J. Hazes, M. De Jager, N. Basoski, C. Haagsma, J. Luime, A. Gerards
Description of data: univariate and multivariate logistic regression in the multiple imputation dataset (Mâ =â 10) using STATA 12 and REALCOM. (DOC 44 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d3b1e8d7afe999c598e4ca7d0a5aaa1
Autor:
Ledón-Llanes, Loraine1 (AUTHOR), Contreras-Yáñez, Irazú2 (AUTHOR), Guaracha-Basáñez, Guillermo Arturo2 (AUTHOR), Valverde-Hernández, Salvador Saúl2 (AUTHOR), Cuevas-Montoya, Maximiliano2 (AUTHOR), Ortiz-Haro, Ana Belén2 (AUTHOR), Pascual-Ramos, Virginia2 (AUTHOR) virtichu@gmail.com
Publikováno v:
PLoS ONE. 8/26/2024, Vol. 19 Issue 8, p1-18. 18p.
Autor:
Jiménez-Jiménez, Félix Javier1 (AUTHOR) fjavier.jimenez@salud.madrid.org, Alonso-Navarro, Hortensia1 (AUTHOR) paula.salgado.camara@gmail.com, Salgado-Cámara, Paula1 (AUTHOR), García-Martín, Elena2 (AUTHOR) elenag@unex.es, Agúndez, José A. G.2 (AUTHOR) jagundez@unex.es
Publikováno v:
International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 12, p6289. 20p.